Predicting Dysplasia and Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Development of a Preoperative Nomogram

[1]  K. Campbell,et al.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience , 2004, Annals of surgery.

[2]  M. Gonen,et al.  Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. , 2011, Journal of the American College of Surgeons.

[3]  J. Drebin.  18-Fluorodeoxyglucose Positron Emission Tomography Enhances Computed Tomography Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2008 .

[4]  D. Sahani,et al.  Prospective evaluation of reader performance on MDCT in characterization of cystic pancreatic lesions and prediction of cyst biologic aggressiveness. , 2011, AJR. American journal of roentgenology.

[5]  M. Gonen,et al.  Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2010, Annals of Surgical Oncology.

[6]  C. Bassi,et al.  Pancreatic cystic tumours: when to resect, when to observe. , 2010, European review for medical and pharmacological sciences.

[7]  Jeong Min Lee,et al.  Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas , 2013, Journal of magnetic resonance imaging : JMRI.

[8]  A. Warshaw,et al.  Cystic lesions in the pancreas: When to watch, when to resect , 2000, Current gastroenterology reports.

[9]  H. Pitt,et al.  Cystic Pancreatic Neoplasms: Observe or Operate , 2004, Annals of surgery.

[10]  J. Wong,et al.  High-Grade Dysplasia and Adenocarcinoma Are Frequent in Side-Branch Intraductal Papillary Mucinous Neoplasm Measuring Less than 3 cm on Endoscopic Ultrasound , 2012, Journal of Gastrointestinal Surgery.

[11]  F. Chierichetti,et al.  Value of 18-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients With Cystic Tumors of the Pancreas , 2001, Annals of surgery.

[12]  M. D'Angelica,et al.  Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation , 2013, Annals of Surgical Oncology.

[13]  Bechien U. Wu,et al.  Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  Jae Young Lee,et al.  Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: Comparison of multirow‐detector CT and MR imaging using ROC analysis , 2007, Journal of magnetic resonance imaging : JMRI.

[15]  M. D'Angelica,et al.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Analysis of Clinicopathologic Features and Outcome , 2004, Annals of surgery.

[16]  Taketo Yamaguchi,et al.  Preoperative Histological Subtype Classification of Intraductal Papillary Mucinous Neoplasms (IPMN) by Pancreatic Juice Cytology With MUC Stain , 2013, Annals of surgery.

[17]  S. Thayer,et al.  Current trends in pancreatic cystic neoplasms. , 2009, Archives of surgery.

[18]  Elizabeth Lee-Lewandrowski,et al.  Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. , 2004, Gastroenterology.

[19]  M. Büchler,et al.  Small (Sendai Negative) Branch-Duct IPMNs: Not Harmless , 2012, Annals of surgery.

[20]  Michelle A. Anderson,et al.  Risk of Malignancy in Resected Cystic Tumors of the Pancreas ≤3 cm in Size: Is it Safe to Observe Asymptomatic Patients? A Multi-institutional Report , 2008, Journal of Gastrointestinal Surgery.

[21]  N. Rofsky,et al.  Prevalence of Incidental Pancreatic Cysts in the Adult Population on MR Imaging , 2010, The American Journal of Gastroenterology.

[22]  Jin-Young Jang,et al.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[23]  F. Chierichetti,et al.  Comparison of International Consensus Guidelines Versus 18-FDG PET in Detecting Malignancy of Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2011, Annals of surgery.

[24]  S. Chari,et al.  International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.

[25]  A. Levy.  Prevalence of Unsuspected Pancreatic Cysts on MDCT , 2009 .

[26]  M. Gonen,et al.  A Selective Approach to the Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients , 2006, Annals of surgery.

[27]  G. Rechavi,et al.  MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas. , 2013, Surgery.

[28]  S. Larson,et al.  The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas , 2006, Journal of Gastrointestinal Surgery.

[29]  T. Gardner,et al.  The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  L. Qin,et al.  Pancreatic Cyst Fluid Protein Expression Profiling for Discriminating Between Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm , 2009, Annals of surgery.